IV to Subcutaneous Infliximab Switch Shows Promise in IBD ...Middle East

Medscape - News
IV to Subcutaneous Infliximab Switch Shows Promise in IBD
Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable disease course and is both effective and safe for patients with IBD. Medscape News UK

Hence then, the article about iv to subcutaneous infliximab switch shows promise in ibd was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( IV to Subcutaneous Infliximab Switch Shows Promise in IBD )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News